🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The purpose of this study is to evaluate efficacy and safety of Irbesartan ...
Status
Completed
Location
Severance Hospital
Start Date
2022-07-05
Trial ID
NCT05476354
Treatments Being Tested
This study will assess the reno-protective effect of renin inhibition with ...
Status
Completed
Location
Novartis
Start Date
2005-09
Trial ID
NCT00464880
Treatments Being Tested
This randomized,active controlled study aimed to compare the effects on sex...
Status
Unknown
Location
The Second Hospital of Lanzhou University
Start Date
2008-04
Trial ID
NCT01238705
Treatments Being Tested
Primary: 1. To compare the change in forearm vascular resistance following...
Status
Completed
Location
Sanofi-Aventis
Start Date
2006-09
Trial ID
NCT00443612
Treatments Being Tested
To compare the antihypertensive efficacy of the combination irbesartan/hydr...
Status
Completed
Location
Sanofi-Aventis Administrative Office
Start Date
2008-06
Trial ID
NCT00708344
Treatments Being Tested
ANCA-associated vasculitis is an autoimmune disease that causes damage to b...
Status
Active Not Recruiting
Location
Centre for Cardiovascular Science, Queen's Medical Research Institute, 47 Little France Crescent
Start Date
2022-12-08
Trial ID
NCT05630612
Treatments Being Tested
Jangzhuo Qinggan prescription and irbesartan in the treatment of essential ...
Status
Unknown
Location
Beijing Medical University ,Dongzhimen Hospital
Start Date
2010-03
Trial ID
NCT01082835
The purpose of this study is to evaluate efficacy and safety of Irbesartan ...
Status
Completed
Location
Hanyang University Seoul Hospital
Start Date
2022-07-14
Trial ID
NCT05475665
Treatments Being Tested
The purpose of this study is to determine whether bindarit is effective to ...
Status
Completed
Location
Azienda Ospedaliera OO.RR. Bergamo - Unità Operativa Diabetologia
Start Date
2007-03
Trial ID
NCT01109212
The purpose of this study was to determine if Irbesartan compared to Placeb...
Status
Completed
Location
Sanofi-Aventis Administrative Office
Start Date
2003-06
Trial ID
NCT00249795
Treatments Being Tested